XORTX Therapeutics Inc. is a Vancouver-based biopharmaceutical company focused on innovative therapies for progressive kidney disease and related metabolic disorders such as hypertension, insulin resistance, and diabetic nephropathy. With a commitment to addressing significant unmet medical needs, XORTX is advancing its proprietary drug candidates through clinical development, aiming to enhance patient outcomes and quality of life. The company leverages cutting-edge research and strategic partnerships to facilitate the commercialization of its therapies in the evolving healthcare market.
Click "Analyze" to generate stock analysis
XRTX Price Trend and Signals
XRTX Financials
2025-10-28Somewhat Bearishprice_signal
Yearly low detected.
2025-10-22Somewhat Bearishprice_signal
Yearly low detected.
2025-10-21Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-21Somewhat Bearishprice_signal
Yearly low detected.
2025-10-20Somewhat Bearishprice_signal
Monthly low detected.
2025-10-20Bearishprice_signal
Large price change detected: -31.82%.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.